Drägerwerk Stock: Positive Impact Expected
Drägerwerk AG & Co. KGaA, a leading specialist in medical and safety technology, has recorded an impressive annual increase of over 36 percent despite current price fluctuations. This positive trend is supported by several factors:
Dividend Policy
Drägerwerk plans to increase the dividend for the year 2024. The board proposes a payout of 1.97 euros per ordinary share and 2.03 euros per preference share, which represents an increase from the 1.74 euros and 1.80 euros in 2023, respectively. This decision is part of a new dividend policy that stipulates distributing at least 30 percent of the group profit to shareholders.
Business Development
In the fiscal year 2024, Dräger achieved sales of nearly 3.4 billion euros, which corresponds to a currency-adjusted decline of 0.5 percent. Despite challenging market conditions in China, particularly in the medical technology segment, earnings before interest and taxes (EBIT) increased by more than 16 percent to 194 million euros. Incoming orders were around 3.38 billion euros, exceeding last year’s levels due to strong demand in the medical and safety technology sectors.
Stock Price Development
The Drägerwerk stock has shown a pleasing development in recent months. On March 27, 2025, the stock reached a 52-week high of 65.10 euros. Despite short-term fluctuations, the stock displays stable performance with an annual growth of over 20 percent.
Analyst Support
The positive development of Drägerwerk is supported by analysts. The valuation situation with a price-earnings ratio (P/E) of 10.87 for the year 2025 and a low price-to-cash flow ratio of 2.71 suggests an interesting positioning of the company. This could be a positive signal for private investors.
Innovation and Future Outlook
Drägerwerk relies on innovation to maintain its edge in medical and safety technology. The upcoming quarterly results are eagerly awaited, as they may provide further insights into business development. For the current year, Dräger expects a currency-adjusted sales increase of between 1 and 5 percent.
Overall, Drägerwerk shows solid business development and a positive outlook, reflected in the dividend increase and analyst support. Despite current price fluctuations, the stock remains attractive for investors.